Endothelial dysfunction precedes atherosclerosis in systemic sclerosis--relevance for prevention of vascular

G Szucs1, O Tímár, Z Szekanecz

  • 13rd Department of Internal Medicine, Rheumatology Division, University of Debrecen, Medical and Health Science Center, Hungary, Móricz Zs krt. 22., H-4004 Debrecen, Hungary.E-mail: szekanecz@iiibel.dote.hu.

Insights

Systemic sclerosis (SSc) patients show impaired endothelium-dependent vasodilation (FMD), but preserved endothelium-independent vasodilation (NMD). Early FMD assessment in SSc may aid diagnosis and treatment.

Area of Science:

  • Vascular Medicine
  • Rheumatology
  • Cardiology

Background:

  • Systemic sclerosis (SSc) is characterized by vasculopathy and endothelial dysfunction.
  • Endothelial dysfunction contributes to the pathogenesis of SSc.

Purpose of the Study:

  • To investigate endothelium-dependent, flow-mediated dilatation (FMD) and endothelium-independent, nitroglycerin-mediated dilatation (NMD) of the brachial artery in SSc patients.
  • To assess common carotid intimal-medial thickness (ccIMT) in SSc patients compared to healthy controls.

Main Methods:

  • High-resolution ultrasound imaging was used to measure FMD and NMD in the brachial artery.
  • Duplex color ultrasound assessed ccIMT in the common carotid arteries.
  • 29 SSc patients and 29 healthy controls were included, with similar demographics and cardiovascular risk factors.

Main Results:

  • SSc patients exhibited significantly lower FMD compared to controls (4.82% vs. 8.86%, P < 0.001).
  • No significant difference in NMD was observed between SSc patients and controls (P > 0.1).
  • A trend towards increased ccIMT was noted in SSc patients (0.67 mm vs. 0.57 mm, P = 0.067), correlating with age and disease duration.

Conclusions:

  • SSc is associated with impaired endothelium-dependent vasodilation (low FMD).
  • Endothelium-independent vasodilation (NMD) remains preserved, suggesting potential for nitroglycerin therapy.
  • ccIMT may indicate carotid atherosclerosis in older SSc patients with longer disease duration; FMD assessment could be diagnostically and prognostically valuable.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...